Michael L. Marberry

Chief Executive Officer, President and Director, J
pathology
SigmaAldrich
United States of America

Business Expert Pathology
Biography

  Mr. Michael L. Marberry, also known as Mike, has been the Chief Executive Officer and President at J.M. Huber Corporation (also known as Huber (J.M.) Corp.) since 2009. Mr. Marberry has been with Huber since 1997. He has more than 31 years of management experience, including more than 16 years with J. M. Huber Corporation. He served as President of Huber Engineered Materials (HEM) from September 11, 2006 to 2009. He served as the Chief Financial Officer of J.M. Huber Corporation from 2002 to 2006 and Corporate Vice President of Strategy and New Business Development from 1997 to 2002. Prior to joining Huber, he served in senior roles at M.A. Hanna Company, a specialty polymers company in Cleveland, Ohio and in various roles with McKinsey & Company, Inc. and The Proctor and Gamble Company. Mr. Marberry was involved with a number of prior strategic moves that helped shape HEM, including the combination of Huber's chemicals and minerals businesses to form HEM as a single unit. He also led Huber's mergers and acquisitions activity. He has been Independent Chairman at AdvanSix Inc. since October 01, 2016 and has been its Director since September 12, 2016. He has been a Director of Sigma-Aldrich Corporation since September 2012. He has been a Director of J.M. Huber Corporation since 2009. He serves as a Director of Sigma-Aldrich Company Limited. He serves as a Director of National Association of Corporate Directors (“NACD”) Governance Fellow. He is an audit committee financial expert. Mr. Marberry earned his M.B.A. from Amos Tuck School of Business Administration at Dartmouth College and his M.S. and B.S. in Chemical Engineering from the University of Kentucky.                          

Research Intrest

 pathology